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ABSTRACT
Objective: Neurodegenerative diseases, such as
dementia, have a profound impact on those with the
conditions and their family carers. Consequently, the
accurate measurement of family carers’ quality of life
(QOL) is important. Generic measures may miss key
elements of the impact of these conditions, so using
disease-specific instruments has been advocated. This
systematic review aimed to identify and examine the
psychometric properties of disease-specific outcome
measures of QOL of family carers of people with
neurodegenerative diseases (Alzheimer’s disease and
other dementias; Huntington’s disease; Parkinson’s
disease; multiple sclerosis; and motor neuron disease).
Design: Systematic review.
Methods: Instruments were identified using 5
electronic databases (PubMed, PsycINFO, Web of
Science, Scopus and the International Bibliography of
the Social Sciences (IBSS)) and lateral search
techniques. Only studies which reported the
development and/or validation of a disease-specific
measure for adult family carers, and which were
written in English, were eligible for inclusion. The
methodological quality of the included studies was
evaluated using the COnsensus based Standards for
the selection of health Measurement Instruments
(COSMIN) checklist. The psychometric properties of
each instrument were examined.
Results: 676 articles were identified. Following
screening and lateral searches, a total of 8 articles were
included; these reported 7 disease-specific carer QOL
measures. Limited evidence was available for the
psychometric properties of the 7 instruments.
Psychometric analyses were mainly focused on internal
consistency, reliability and construct validity. None of
the measures assessed either criterion validity or
responsiveness to change.
Conclusions: There are very few measures of carer
QOL that are specific to particular neurodegenerative
diseases. The findings of this review emphasise the
importance of developing and validating
psychometrically robust disease-specific measures of
carer QOL.
INTRODUCTION
Neurodegenerative diseases have a profound
impact as they lead to a prolonged and irre-
versible decline in global intellectual, social
and physical functioning. People living with
neurodegenerative diseases tend to progres-
sively lose their independence and require
increased levels of care and support.
Dementia is the most common type of neuro-
degenerative disease, affecting 800 000
people in the UK alone,1 and costing £26.3
billion to society each year.2 Family members,
friends and neighbours who act as carers are
a vital determinant of positive outcomes for
people with neurodegenerative diseases such
as dementia. They provide a wide range of
practical and emotional support, social care,
and assistance with activities of daily living.3
These caregiving tasks include, for example,
help with personal care, managing ﬁnances
and legal affairs, social activities, mobility, and
administering and coordinating medication.3
Strengths and limitations of this study
▪ This study provides the first comprehensive
review of disease-specific instruments measuring
quality of life of family carers of people with
neurodegenerative diseases.
▪ The findings of the review offer guidance to
researchers and clinicians in the selection of
appropriate and psychometrically strong disease-
specific instruments.
▪ Only instruments specific to neurodegenerative
diseases were examined.
▪ We did not review the performance of generic
measures of quality of life.
▪ The instruments identified in this review were
developed specifically for family carers rather
than professional (ie, paid) carers of people with
neurodegenerative diseases.
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Caring for a person with a neurodegenerative disease
may result in multiple negative outcomes, including
increased anxiety and depression, stress, exhaustion,
social isolation, and concerns about the future.1
Nevertheless, caring can also have positive effects such
as greater closeness to the person with the condition,
reciprocity and spiritual growth.4–6 In recent years, there
has been an increasing research focus on assessing
quality of life (QOL) as an informative and important
patient-reported outcome measure in the person with
the disease and their carers. Although QOL is subjective
in regard to how it is perceived by the individual, there
is growing consensus that it represents a multidimen-
sional construct encompassing various domains such as
physical health, socioeconomic status; psychological,
emotional and social well-being, and that it is a useful
way of capturing the broad impacts of complex disorders
such as neurodegenerative disease.7 In this paper, follow-
ing the recommendations of our carer consultation, the
term ‘family carer’ is used to refer to all ‘informal’
carers (ie, not paid carers), including family members,
neighbours and friends of a person with a neurodegen-
erative disease. This also includes people who are not, in
fact, family members, since the term ‘informal’ was seen
as minimising and trivialising the nature of the care pro-
vided, and the term ‘carer’ by itself was seen as too
imprecise.
Given the important role of family carers, it is essential
for the person with the illness as well as for the carer,
that carers of people with neurodegenerative diseases
maintain a good QOL. Carer QOL is likely to be asso-
ciated with patient QOL, and when carer QOL deterio-
rates, there is likely to be a higher risk that the person
with dementia will need admission into a care home, so
driving lower life quality and higher societal cost. It is
also important to measure the broad QOL carer impacts
of interventions for the person with dementia and for
carers. To ensure this can be monitored effectively, it is
necessary to measure carer QOL accurately using psy-
chometrically robust measures. To date, QOL of affected
individuals and their carers has been predominantly
assessed using generic health status instruments such as
the SF-368 and the EQ-5D.9 Disease-speciﬁc instruments
have been used much less frequently. This is problematic
as generic instruments miss issues that are pertinent to
speciﬁc conditions and, consequently, are less responsive
to detecting changes in carer QOL over time.10 11 For
example, an increased level of support received as a
carer has been associated with better carer QOL in
dementia,4 but neither the EQ-5D nor the SF-36 capture
such a construct.
An earlier review has examined the effects (eg, phys-
ical, social, emotional, ﬁnancial) of caring for an elderly
family member with dementia on carer QOL.11
Disease-speciﬁc and generic instruments were identiﬁed
that assess QOL of either patients with dementia or
their carers. However, the psychometric properties of
these measures were not reported or discussed, and the
review focused exclusively on dementia and Alzheimer’s
disease. Building on this, we therefore completed a sys-
tematic review to identify and examine the disease-
speciﬁc instruments that measure QOL of family carers
of people with a neurodegenerative disease. Here,
we examine the psychometric properties of these
instruments.
METHODS
The systematic review was conducted and reported in
accordance with the recommendations from the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement.12
Inclusion criteria
Instruments were included in the review if they satisﬁed
the following criteria: (1) the study described the devel-
opment (inauguration paper) and/or the evaluation of
the psychometric properties and relationships with other
relevant constructs (validation paper) of a measure of
carer QOL; (2) the study population were adult (aged
18 years or above) family (deﬁned as family members,
neighbours or friends) carers of people with a neurode-
generative disease (dementia, Alzheimer’s disease,
Parkinson’s disease (PD), Huntington’s disease (HD),
multiple sclerosis (MS) and motor neuron disease); (3)
the instrument was designed to be disease-speciﬁc and
not a generic measure of QOL; (4) studies only docu-
mented instruments that were self-report in their design.
Any studies that reported an eligible measure (eg, as an
outcome in a clinical trial) without any explicit valid-
ation were excluded; and (5) studies were written in
English.
Search strategy
Articles were identiﬁed from initial searches of ﬁve elec-
tronic databases: PubMed, PsycINFO, Scopus, Web of
Science and the International Bibliography of the Social
Sciences (IBSS). The searches were conducted from
inception until 8 February 2016. All articles identiﬁed
up until this time were screened regardless of their pub-
lication date. We used the following ﬁve combined sets
of search terms: (1) ‘quality of life’; AND (2) caregiver*
OR carer*; AND (3) informal OR unpaid OR spous*
OR family; AND (4) dementia OR alzheimer* OR par-
kinson* OR huntington* OR multiple sclerosis OR
motor neurone disease; AND (5) valid* OR reliab* OR
development OR psychometric. The search terms were
intentionally broad and sensitive enough to ensure that
all potentially relevant articles were identiﬁed (please
see online supplementary material ﬁle for full details of
search strategy). Six additional articles were obtained
using lateral searching techniques.13 These searches
involved the manual checking of reference lists of
included studies (snowballing), citation searches using
the ‘Cited by’ option on Web of Science, Google
Scholar, and Scopus, and the ‘Related articles’ option
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on PubMed and Web of Science (lateral searching). The
grey literature (ie, unpublished studies) was also
searched using the following databases: OpenGrey and
Patient-Reported Outcome and Quality of Life
Instruments Database (PROQOLID). We attempted to
make direct contact (via email) with the authors of a
manuscript when no published psychometric data were
available for the instrument being reported. Two inde-
pendent reviewers (TEP and NF) screened article titles
and abstracts against the predeﬁned inclusion criteria.
Full-text articles were sought for all potentially relevant
studies. Any disagreements concerning inclusion were
resolved through discussion and advice from a third
reviewer (SD).
Data extraction
Two reviewers (TEP and NF) extracted, independently,
the following data for studies that met the inclusion cri-
teria: name of the instrument, country, sample
characteristics (gender, age), study design/setting, meas-
urement domains, number of items, response format,
evidence of reliability and validity.
Quality assessment
The methodological quality of the studies was assessed
using the COnsensus based Standards for the selection
of health Measurement Instruments (COSMIN) check-
list.14–16 This is a standardised tool which assesses the
measurement properties of health-related instruments
across nine domains (internal consistency, reliability,
measurement error, content validity (including face val-
idity), construct validity (subdivided into structural valid-
ity, hypotheses testing and cross-cultural validity),
criterion validity and responsiveness) with each domain
rated using 5–18 items. Each item is rated as ‘excellent’,
‘good’, ‘fair’ or ‘poor’ quality. A methodological quality
score for each measurement property is obtained by
taking the lowest rating of any item in that box (worst
score counts). Two independent reviewers (TEP and
NF) assessed the methodological quality of the included
studies using the checklist. Any disagreements in scoring
were resolved through discussion and advice from a
third reviewer (SD).
RESULTS
Search results
The initial database searches identiﬁed 676 articles, of
which 232 were deleted because of duplicates. After title
and abstract screening, we assessed seven articles as
potentially relevant and obtained full texts. From review-
ing the full texts of these remaining articles, we found
two studies that met inclusion criteria (ﬁgure 1). Six
additional articles were identiﬁed using lateral search
techniques.
In total, we included eight studies in the systematic
review and these reported seven carer QOL instruments
across the neurodegenerative diseases. All of them were
self-report measures and consisted of the HD
quality-of-life battery for carers (HDQoL-C);17 HD
quality-of-life battery for carers-short form (HDQoL-C-
SF);18 CAREQOL-MS for MS;19 Alzheimer’s Carers
Quality of Life Instrument (ACQLI);20 Parkinson Disease
Questionnaire for Carers (PDQ-Carer);21 Parkinsonism
Carers QoL (PQoL Carers);22 and the Caregiver Quality
Of Life for dementia (CGQOL).6 We did not identify
any instruments designed to measure the QOL of carers
of people with motor neuron disease.
Study characteristics
The sample characteristics for the eight studies assessing
the carer QOL instruments are presented in table 1.
The total sample sizes of these studies ranged from
8717 to 430.22 The studies recruited participants from
the UK,17 21–23 Spain19 and the USA.6 The remaining
two studies recruited participants across multiple coun-
tries which included France, Italy and Germany.18 20
The mean age of participants across the eight studies
was 61.2 years. The number of measurement domains of
the instruments ranged from 1 (ACQLI, PQoL Carers)
to 10 (CGQOL). The number of items of these instru-
ments ranged from 20 (HDQoL-C-SF) to 80 (CGQOL).
All measures used Likert-type rating scales (ranging
from 3-point to 11-point), except for the ACQLI which
used a dichotomous (true/not true) response format.
Methodological quality of studies
Table 2 provides a summary of the scores from the
COSMIN checklist. Six of the eight studies (75%)
included in the review had at least one methodological
domain rated as ‘poor’ quality.6 17–21 Across all studies,
the measurement property that received the highest
number of ‘poor’ ratings was content validity (4/8
studies). Five of the eight studies (63%) had at least one
methodological domain rated as of ‘fair’ quality.6 18 21–23
The measurement property that received the highest
number of ‘fair’ ratings was internal consistency (5/8
studies). Of the 8 studies, 2 (26%) had at least one area
of methodological quality rated as ‘good’ or ‘excel-
lent’.19 22 The measurement properties that received
‘good’ ratings were reliability and measurement error.19
The measurement properties that received ‘excellent’
ratings were internal consistency, structural validity19 and
content validity.22
Psychometric properties of the carer QOL instruments
The instruments that had allowed the most comprehen-
sive evaluation of psychometric properties across the
9 domains of the COSMIN checklist were the
CAREQOL-MS (5/9 domains assessed) and the CGQOL
(5/9 domains assessed). The HDQoL-C, HDQoL-C-SF
and ACQLI each had four of the nine domains evaluated.
The measures that had the least evidence available for
their psychometric properties were the PQoL Carers
(3/9 domains assessed), the PDQ-Carer (3/9 domains
assessed) and the summary index of the PDQ-Carer
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(2/9 domains assessed). Internal consistency was the
most widely assessed measurement property, and was
examined in all seven instruments. Cronbach’s α coefﬁ-
cients for the total scale and instrument subscales ranged
from 0.75 to 0.94 (see table 3 for an overview of the
psychometric properties of each carer QOL instrument).
Reliability of the measures was reported in 4/8
studies.6 17 19 20 These studies computed test–retest reli-
ability over 2–3 weeks time interval through calculation
of Pearson or Spearman correlations. Intraclass correl-
ation coefﬁcients (ICCs) were also used to assess the
test–retest reliability of individual subscales in two instru-
ments: the CAREQOL-MS and CGQOL. ICCs ranged
between 0.53 and 0.95 for all subscales across these two
measures. The CAREQOL-MS was the only instrument
to calculate measurement error.
Content validity was evaluated in 5/8 studies.17 19 20–22
Structural validity was assessed in 7/8 studies.6 17–19 21–23
Principal components analysis (PCA) was the most fre-
quently employed method of statistical analysis for
examining structural validity. No studies included the
use of conﬁrmatory factor analysis (CFA) with either
continuous or categorical variables (also known as item
response theory (IRT)) to assess factorial structure.
Correlational and known group analyses were most
commonly used to assess convergent and discriminant
validity. However, hypotheses testing was carried out for
only two instruments; the HDQoL-C-SF18 and the
CGQOL.6 Cross-cultural validity was evaluated for three
measures: the HDQoL-C-SF,18 ACQLI20 and CGQOL.6
None of the instruments assessed criterion validity or
responsiveness.
Constructs assessed by the carer quality of life
instruments
Huntington’s disease
As displayed in table 3, the HDQoL-C consists of four
measurement domains (demographic and objective
information; practical aspects of caregiving; satisfaction
with life; feelings about living with HD) which assess the
Figure 1 PRISMA flow diagram
of study selection. PRISMA,
Preferred Reporting Items for
Systematic Reviews and
Meta-Analyses; QOL, quality of
life.
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Table 1 Characteristics of the included studies
Carer QOL
Instrument Author(s) Country
Sample
Total N (% female)
Mean age years
(SD) Study design/setting Measurement domains
Number of items/
response format
HDQoL-C Aubeeluck and
Buchanan17
UK 87 (62.1)
58.2 (14.2)
Longitudinal/cohort: spousal
carers recruited through the
Huntington’s Disease
Association UK
Demographic and objective information;
practical aspects of caregiving;
satisfaction with life; feelings about
living with Huntington’s disease
34 items
11-point Likert scale
HDQoL-C-SF Aubeeluck
et al18
France
Italy
301 (60.5)
57.1 (13.1)
Cross-sectional survey: family
or friend carers of people with
Huntington’s disease
Satisfaction with life; feelings about
living with Huntington’s disease
20 items
11-point Likert scale
CAREQOL-MS Benito-Leon
et al19
Spain 276 (56.5)
50.2 (12.6)
Longitudinal/cohort: family
carers of people with MS
recruited from 19 Spanish
outpatient clinics
Physical burden and global health;
social impact; emotional impact; need
of support; emotional reactions to
patient’s psychic status
24 items
5-point Likert scale
ACQLI Doward20 UK
France
Germany
Italy
Spain
192 (72.3)
60.0 (12.2)
Longitudinal/cohort: family
carers of people with dementia
Single domain of carer QOL 30 items
Dichotomous (true/
not true)
PDQ-Carer Jenkinson
et al21
UK 236 (63.5)
68.2 (9.5)
Cross-sectional survey: family
carers of people with
Parkinson’s disease who were
members of Parkinson’s UK
Social and personal activities; anxiety
and depression; self-care; stress
29 items
5-point Likert scale
PDQ-Carer-SI Morley et al23 UK 236 (63.5)
68.2 (9.5)
Cross-sectional survey: family
carers of people with
Parkinson’s disease who were
members of Parkinson’s UK
Single summary index score computed
using the four subscales of the
PDQ-Carer
29 items
5-point Likert scale
PQoL Carers Pillas et al22 UK 430 (62.4)
66.2 (8.5)
Cross-sectional survey: family
carers of people with MSA and
PSP
Single domain of carer QOL 26 items
5-point Likert scale
CGQOL Vickrey et al6 USA 200 (79.0)
61.5 (13.5)
Longitudinal/cohort: family
carers of people with dementia
Assistance with instrumental activities
of daily living; assistance with activities
of daily living; role limitations due to
caregiving; personal time; family
interaction; demands of caregiving;
worry; spirituality and faith; benefits of
caregiving; caregiver feelings
80 items
3-point and 5-point
Likert scales specific
to groups of items
ACQLI, Alzheimer’s Carers Quality of Life Instrument; CGQOL, Caregiver Quality Of Life; HDQoL-C, Huntington’s disease quality-of-life battery for carers; HDQoL-C-SF, Huntington’s disease
quality-of-life battery for carers short form; MS, multiple sclerosis; MSA,multiple system atrophy; PDQ-Carer, Parkinson Disease Questionnaire for Carers; PDQ-Carer-SI, Parkinson Disease
Questionnaire for Carers Summary Index; PQoL Carers, Parkinsonism Carers QoL; PSP,progressive supranuclear palsy; QOL, quality of life.
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QOL of spousal carers of people with HD. It is a 34-item
instrument which employs an 11-point Likert-type
response scale. PCA using varimax rotation was per-
formed separately on each set of items for three of the
four domains (not the component of demographic and
objective information). This identiﬁed three subcompo-
nents for the ﬁrst component of ‘practical aspects of
care giving’ (levels of support and access to profes-
sionals; long-term and genetic issues; daily hassles). PCA
on the third domain of ‘satisfaction with life’ extracted
two subcomponents (overall QOL issues; personal
issues). Finally, PCA on the fourth domain of ‘feelings
about living with HD’ resulted in the identiﬁcation of
two subcomponents (negative feelings about life; posi-
tive feelings about life).
The short form of the HDQoL-C measures two of the
four domains of the original instrument (satisfaction
with life; feelings about living with HD). It is a 20-item
measure using an 11-point Likert-type response scale.
Exploratory factor analysis (EFA) using varimax rotation
was performed on the 17 items of the ‘feelings about
living with HD’ subscale. This resulted in the extraction
of the two subcomponents of ‘negative feelings about
life’ and ‘positive feelings about life’ which accounted
for 84% of the total variance. Factor analysis was not per-
formed on the ‘satisfaction with life’ subscale as only
three items were retained from the full-length measure.
In addition to the English language version of the
HDQoL-C, the measure was translated into French and
Italian.
Multiple sclerosis
The CAREQOL-MS measures QOL in carers of people
with MS. It consists of 24 items and uses a ﬁve-point
Likert-type response format. PCA using orthogonal rota-
tion (unspeciﬁed method of rotation) extracted four
factors identiﬁed as ‘physical burden and global health’,
‘emotional impact’, ‘need of support’ and ‘emotional
reactions to patient’s psychic status’ explaining 60% of
the total variance. The ﬁrst factor was later subdivided
to include a separate subscale of ‘social impact’.
Parkinson’s disease
The PDQ-Carer measures QOL in carers of people with
PD. This instrument contains 29 items and uses a ﬁve-
point Likert-type response format. EFA using varimax
rotation identiﬁed four factors: social and personal activ-
ities, anxiety and depression, self-care, and stress. These
factors explained 60% of the total variance.
The PQoL Carers is an alternative measure of QOL in
family carers of people with PD. This instrument con-
tains 26 items and uses a ﬁve-point Likert-type response
format. Parallel analysis was performed to assess the
dimensionality of the scale which identiﬁed a single
factor structure (representing overall QOL), explaining
54% of the total variance.
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Table 3 Evidence of the reliability and validity of the carer QOL instruments
Reliability Validity
Carer QOL
instrument Author(s) Internal consistency Test–retest Measurement error Content validity Construct validity
HDQoL-C Aubeeluck
and
Buchanan17
Not provided for total
scale. Subscale α:
0.80, 0.84, 0.89
Test–retest (N=10) over
2 weeks. Pearson
correlation: 0.78, 0.86,
0.90 for subscales
Not assessed Two experts in the field of
QOL and two experts in
the field of HD commented
on item content
Convergent validity: positive
correlations of HDQoL-C
subscales with
WHOQOL-BREF,
Satisfaction with Life Scale,
and Perceived Health Visual
Analogue Scale
HDQoL-C-SF Aubeeluck
et al18
Not provided for total
scale. Subscale α:
0.88, 0.80
Not assessed Not assessed Not assessed Known groups analyses
showed that HDQoL-C-SF
scores were higher (better
carer QOL) for carers of
patients in the low disease
severity group compared
with the moderate and high
severity groups
CAREQOL-MS Benito-Leon
et al19
Not provided for total
scale. Subscale α:
0.90, 0.85, 0.81, 0.78,
0.75
Test–retest (N=276) over
2 weeks. ICC for total
scale score=0.96 and
ranged from 0.75 to 0.95
for subscales. Cohen’s κ
ranged from 0.46 to 0.93.
One item had κ<0.60
and 15 items had
κ≥0.80.
SE of measurement
ranged from 0.91 to
2.43 across the five
subscales over
2 weeks time
interval.
Item content analysed by
MS experts. Focus groups
of MS carers and patients
discussed item pool. Items
rated for clarity and
meaning by MS experts
and a separate carer
sample
Convergent validity: positive
correlations of
CAREQOL-MS subscales
with Zarit Burden Interview.
Moderate-to-high negative
correlations of
CAREQOL-MS subscales
with physical and mental
components of SF-36
ACQLI Doward20 α ranged between 0.87
and 0.95 across the
UK, France, Germany,
Italy and Spain for
times 1 and 2
administrations of the
ACQLI.
Test–retest over 2 weeks.
Spearman correlations
were 0.93, 0.92, 0.95,
0.94, 0.90 for UK,
France, Germany, Italy
and Spain, respectively.
Based on very small N
per country
Not assessed Field test of items with
samples of carers. States
that carers found the
ACQLI to be
understandable,
acceptable and relevant
across all countries
Convergent validity: positive
spearman correlations of
ACQLI with General
Well-being Index in UK and
Italy. Known groups analysis
demonstrated that the
ACQLI can distinguish
between carers based on
their current health status.
PDQ-Carer Jenkinson
et al21
Not provided for total
scale. Subscale α:
0.92, 0.87, 0.86, 0.83
Not assessed Not assessed Very limited assessment of
content validity. Items were
evaluated by focus groups
of researchers and a pilot
sample of carers.
Convergent validity:
moderate-to-high negative
correlations of PDQ-Carer
subscales with physical and
mental components of
SF-36
Continued
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Table 3 Continued
Reliability Validity
Carer QOL
instrument Author(s) Internal consistency Test–retest Measurement error Content validity Construct validity
PDQ-Carer-SI Morley et al23 α=0.94 Not assessed Not assessed Not assessed Convergent validity:
moderate-to-high negative
correlations of PDQ-Carer-SI
score with physical and
mental components of
SF-36
Parkinsonism
Carers QoL
(PQoL Carers)
Pillas et al22 α=0.96 Not assessed Not assessed Very limited assessment of
content validity. The
questionnaire was pilot
tested in a small group of
carers
Convergent validity:
Subscales of PQoL Carers
correlated with Caregiver
Burden Inventory, Hospital
Anxiety and Depression
Scale and the EQ-5D.
ANOVA revealed that PQoL
Carers scores differentiate
between carers based on
their current health status.
Caregiver
Quality Of Life
(CGQOL)
Vickrey et al6 Not provided for total
scale. Subscale α:
0.88, 0.93, 0.78, 0.83,
0.86, 0.86, 0.82, 0.94,
0.92, 0.89
Test-retest (N=71)
between 11 and 63 days
following first
administration (75%
within 21 days). ICC
ranged from 0.53 to 0.89,
exceeding 0.70 for 6 of
the 10 subscales
Not assessed Not assessed Convergent validity:
Regression and correlation
analyses of CGQOL
subscales with a range of
patient and carer
characteristics (e.g. number
of hours spent caregiving,
duration of being a carer)
ACQLI, Alzheimer’s Carers Quality of Life Instrument; CGQOL, Caregiver Quality Of Life; HD, Huntington’s disease; HDQoL-C, Huntington’s disease quality-of-life battery for carers;
HDQoL-C-SF, Huntington’s disease quality-of-life battery for carers short form; ICC, intraclass correlation coefficient; MS, multiple sclerosis; PDQ-Carer-SI, Parkinson Disease Questionnaire for
Carers Summary Index; PQoL Carers, Parkinsonism Carers QoL; QOL, quality of life.
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Dementia and Alzheimer’s disease
The ACQLI measures QOL in carers of people with
Alzheimer’s disease and dementia. This instrument con-
sists of 30 items which use a dichotomous (true/not
true) response format. Structural validity of the ACQLI
has not been evaluated. The items of the measure assess
QOL as a unidimensional construct, but no factor ana-
lysis was reported in the development of this scale. Five
language versions of the ACQLI are available: English,
French, German, Italian and Spanish.
Finally, the CGQOL is the most recently developed
measure of QOL in carers of people with dementia and
Alzheimer’s disease. The instrument contains 80 items
across 10 domains (assistance with instrumental activities
of daily living; assistance with activities of daily living; role
limitations due to caregiving; personal time; family inter-
action; demands of caregiving; worry; spirituality and faith;
beneﬁts of caregiving; caregiver feelings) using either a
three-point or a ﬁve-point Likert-type response format,
with categories speciﬁc to groups of items. These 10 sub-
scales were categorised under three superordinate factors
labelled ‘tangible assistance’ (comprised of assistance (to
the person with dementia) with instrumental activities of
daily living; assistance (to the person with dementia) with
activities of daily living; personal time; role limitations due
to caregiving), ‘psychosocial’ (comprised of role limita-
tions due to caregiving (cross-loaded with tangible assist-
ance); family involvement; demands of caregiving; worry;
caregiver feelings) and ‘beneﬁts/faith’ (comprised of spir-
ituality and faith, and beneﬁts of caregiving) using EFA
with promax rotation. The CGQOL was originally devel-
oped in English and was later translated into Spanish. It is
to be noted that items were translated into Spanish,
reviewed by a second translator and interviews were then
conducted with eight Spanish-speaking carers in which to
assess and reﬁne item wording.
DISCUSSION
We identiﬁed eight studies which report the develop-
ment of seven carer QOL measures in neurodegenera-
tive diseases (ie, dementia and Alzheimer’s disease; HD;
PD; MS). No instruments were identiﬁed that measure
carer QOL in motor neuron disease. The ﬁndings of the
studies, taken together, are potentially of value in
guiding researchers and health professionals in the
selection of an appropriate and psychometrically robust
disease-speciﬁc instrument. The studies demonstrate
some key methodological problems in the current
instruments available to measure carer QOL in these
neurodegenerative diseases and highlight avenues for
future research.
Overall, limited information was available concerning
the psychometric properties of the instruments that
were identiﬁed. Collectively, the studies have shown that
many important elements of psychometric evaluation
were either absent or not sufﬁciently tested during the
development phases of these disease-speciﬁc measures.
This review found that the CAREQOL-MS19 and the
CGQOL6 received the most comprehensive psychomet-
ric evaluation, whereas the PQoL Carers22 and the
PDQ-Carer21 (including the validation of the summary
index23) had the least information available on their
psychometric properties.
Internal consistency was the most widely reported psy-
chometric property and was available for all seven instru-
ments. This was quite strong across the studies with
Cronbach’s α coefﬁcients ranging from 0.75 to 0.94.
Less information was provided for the temporal stability
of the measures. Only four of the instruments reported
test–retest reliability (HDQoL-C, CAREQOL-MS, ACQLI,
CGQOL), and this ranged from being adequate to
excellent over 2–3 weeks period. The CAREQOL-MS was
the only instrument to report measurement error, which
is the more useful ﬁgure than reliability since it controls
for the population variance and is therefore more
readily generalisable to other populations.24
The assessment of factorial structure was generally
limited across all studies. EFA and PCA were the
methods predominantly used by the test developers to
assess dimensionality. However, no factor analysis was
reported for the development of the ACQLI, despite the
underlying assumption that it is a unidimensional
measure of carer QOL. Moreover, none of the studies
had performed CFA as a hypothesis-driven test of struc-
tural validity. All identiﬁed studies disregarded the cat-
egorical nature of responses and treated them as
continuous for the purposes of factor analysis. While this
approximation may be acceptable for items using ﬁve or
more categories,25 it is generally untenable for dichot-
omous items24 such as used in the ACQLI. Future
research using these instruments should investigate
whether the factor structures that were identiﬁed in EFA
will replicate in CFA when the ﬁt of alternative measure-
ment models are tested. It would also be advantageous
for researchers to explore factorial structures using
methods for categorical variables (IRT), such as Rasch
analysis.26 A strong advantage of Rasch analysis is that
different measures of the same attribute can be cali-
brated using the same scale and items can be used for
computerised adaptive testing.27 IRT methods can thus
control for item properties that are difﬁcult in classical
measurement, such as the item difﬁculty or ability to dis-
criminate between varying levels of the attribute.
Interestingly, the factor analyses reported in the
studies reviewed suggest that similar constructs are being
measured by all carer QOL instruments across the
various diseases. These measurement domains include,
for example, an appraisal of caring demands, evaluation
of support received, positive and negative feelings
towards caring, the social impact of caring and negative
health effects due to caring, such as anxiety, depression,
stress and fatigue. In contrast to the other measures, the
CGQOL includes a wider array of QOL domains
believed to be affected by the caring role such as role
limitations and family interaction.
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Correlations with external measures were examined in
all seven instruments. As evidence of convergent validity,
the disease-speciﬁc measures were often found to correl-
ate with generic measures of QOL such as the SF-36 and
the EQ-5D.19 21–23 Known group analysis was frequently
used to evaluate construct validity. For example, the
HDQoL-C-SF differentiated between carers on the basis
of the patients’ disease severity. As reported previously, it
was shown that carers’ scores on the HDQoL-C-SF were
higher (ie, representing better QOL) when caring for
family members whose HD was less severe.18
A limitation of the studies reviewed is that hypotheses
were not formulated in the assessment of construct valid-
ity. The HDQoL-C-SF and CGQOL were the only two
instruments in which hypotheses had been postulated a
priori about the expected relationships among mea-
sures. As such, it was unclear how researchers had antici-
pated their measures to be associated with, or distinct
from, existing scales that measure similar constructs.
Another limitation of the studies included in the review
is that criterion-related validity had not been examined
or even considered as an important issue. More import-
antly, none of the instruments that we examined had
assessed responsiveness to change. Thus, it is not known
whether these instruments are sensitive to detecting
changes in carers’ QOL over time. Researchers and clin-
icians need to measure whether interventions and ser-
vices are effective in improving carer QOL. The lack of
known responsiveness to change in these existing mea-
sures could, therefore, be problematic for those seeking
to administer these measures within intervention pro-
grammes and social care settings. The growing use of
QOL as a primary outcome measure in interventional
studies highlights the importance of conducting respon-
siveness analysis on these measures and including such
analyses in the development of future QOL instruments.
Limitations
There are several limitations of the present review that
warrant consideration. First, only articles written in
English were sourced, and this may have led to the exclu-
sion of carer QOL measures that were developed and/or
validated in other languages. Second, this review only
focused on neurodegenerative diseases and did not
examine the psychometric properties of carer QOL mea-
sures developed for other medical conditions. For
example, the Caregiver Quality of Life Index-Cancer
(CQOLC);28 scale is a self-report measure of QOL in
family carers of patients with cancer. In future research, it
would be interesting to compare the psychometric prop-
erties of neurodegenerative disease-speciﬁc measures
with carer QOL instruments across a broader range of
disorders. Third, we only examined the measurement of
QOL of family carers (deﬁned for our purposes as family
members, neighbours or friends) and did not consider
professional (paid) carers. It should be noted, however,
that no articles in this review were excluded during the
screening process on the basis of the carer samples that
were reported. It appears that there are no instruments
developed to measure the speciﬁc QOL impacts on paid
carers. Our systematic review appears to have been suc-
cessful in detecting carer QOL measures that currently
exist across the various neurodegenerative diseases.
CONCLUSIONS
In this systematic review, we provide a comprehensive
overview of disease-speciﬁc instruments to measure QOL
of family carers of people with a neurodegenerative
disease. The included studies had key methodological
limitations associated with the measurement of QOL
using these disease-speciﬁc instruments. These ﬁndings
indicate that there is a need to further develop and
reﬁne these measures and potentially to develop new
measures, in order to improve the psychometric quality
of the measures available. Given the considerable
overlap in the constructs measured by the QOL instru-
ments that we reviewed, it might be useful for research-
ers to explore whether a single measure of carer QOL
for all neurodegenerative diseases would be feasible and
valid. However, due to the heterogeneity in symptoms
and disease course, a rigorous development process is
needed before assuming a single measure would be suf-
ﬁcient. Moreover, it would be advantageous to create
shorter and more concise measures of carer QOL. This
would offer greater brevity and ﬂexibility to researchers
and clinicians who need to administer these instruments
in tandem with a number of other scales. Long instru-
ments such as the 80-item CGQOL6 arguably impose a
greater burden on respondents. Thus, shorter measures
that contain fewer items would beneﬁt respondents by
reducing completion time and reporting burden.
Overall, the ﬁndings of this review should be helpful in
guiding researchers and health professionals in the selec-
tion of an appropriate, and psychometrically robust,
disease-speciﬁc instrument. The accurate assessment of
carer QOL is a growing research priority, and the ﬁndings
of this review are a useful foundation for researchers
seeking to develop and validate new measures of carer
QOL in neurodegenerative disorders. The development
of psychometrically strong, disease-speciﬁc measures of
QOL is important for the generation of better treatments,
services, care and support for people with neurodegenera-
tive disorders and their carers. As demonstrated in this
review, there are few instruments that measure carer QOL
in neurodegeneration, and the psychometric properties of
the few available measures are limited. Further psychomet-
ric testing is needed on existing measures; future valid-
ation studies should include the use of IRT in conjunction
with traditional methods of assessment. There is room for
new instruments with stronger psychometric development,
evaluation and properties in this important area.
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